OncoTherapy Science Inc

30O

Company Profile

  • Business description

    OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

  • Contact

    11th Floor, Kanagawa Science Park R&D
    3-2-1 Sakado
    Kanagawa
    Kawasaki213-0012
    JPN

    T: +81 448208251

    http://www.oncotherapy.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 March 2026

    Employees

    53

Stocks News & Analysis

stocks

Our top ASX picks in every sector

These companies are our top choices for investors wanting to boost Aussie exposure.
stocks

Potentially catastrophic ruling for ASX company

We raise our risk and uncertainty rating to reflect the impact of the ruling.
stocks

4 charts on Nvidia’s record $4 trillion market cap

Shares of the semiconductor giant have rocketed 280% over the past two years amid the AI boom.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,875.3060.000.68%
CAC 407,766.2141.96-0.54%
DAX 4024,060.29100.35-0.42%
Dow JONES (US)44,150.95308.70-0.69%
FTSE 1008,938.3259.74-0.66%
HKSE24,590.12386.801.60%
NASDAQ20,766.65126.320.61%
Nikkei 22539,678.02218.400.55%
NZX 50 Index12,689.6310.940.09%
S&P 5006,264.004.56-0.07%
S&P/ASX 2008,630.3059.900.70%
SSE Composite Index3,505.0014.65-0.42%

Market Movers